Global pharma major Lupin Limited (Lupin) announced the launch of United Food and Drug Administration (FDA) approved bumetanide injection USP, 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL ...
6hon MSN
October saw subdued growth in the Indian pharmaceutical market (IPM), with growth remaining in the low single digits, mainly ...
The Economic Times on MSN15h
Stock market update: Nifty Pharma index 0.81% in an upbeat marketSanofi India Ltd.(down 0.44 per cent) and Lupin Ltd.(down 0.12 per cent) were the top losers on the index. The Nifty Pharma ...
The stock quoted a 52-week high price of Rs 2312.0 and a 52-week low of Rs 1184.0. Shares of Lupin Ltd. traded 0.48 per cent ...
The project entails a production capacity of 14 lakh units and is slated to become operational by the second quarter of FY27 ...
Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,04,083.34 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...
Biopharmaceutical company developing drugs for neurological disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback